Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Dermoscopy is a useful tool for diagnosing and managing alopecia areata.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Etanercept may not prevent alopecia areata from coming back.

Both steroids effectively promote hair growth for at least 9 months.

Platelet-rich plasma (PRP) injections can effectively increase hair density and thickness in people with androgenic alopecia, without major side effects.

Biotin treatment can significantly improve hair loss and motor functions in certain metabolic disorders.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Mice lacking a key DNA methylation enzyme in skin cells have a lower chance of activating stem cells necessary for hair growth, leading to progressive hair loss.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Using both vertical and transverse sections for alopecia biopsies improves diagnosis without extra cost.

The patient's liver did not fully grow back and she had serious temporary side effects after a very large liver surgery.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

Stress might contribute to hair loss in alopecia areata.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Adalimumab may cause severe hair loss in some patients.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

FFA's causes may include environmental triggers and genetic factors.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.